Immunity Diagnostics Cylex specializes in measuring immune cell function with ImmuKnow, an FDA-cleared in vitro diagnostic used to monitor cell-mediated immunity in immunosuppressed populations, presenting a recurring need for clinical collaboration and companion diagnostics opportunities.

Transplant Focus With ImmuKnow adoption by organ transplant centers, there is a clear access point to hospital systems, transplant coordinators, and immunology departments for expanding product reach, service contracts, and potential integration into transplant workflows.

Regulatory & Quality ISO certifications (13485 and 9001) and CMDCAS compliance indicate strong quality and regulatory capabilities, enabling partnerships with other medical device manufacturers, contract research organizations, or global distributors seeking compliant diagnostics solutions.

Global Patents A portfolio of U.S. and Australian patents with pending protections in Europe, Canada, and Japan suggests opportunities to license or co-develop advanced immune monitoring technologies in multinational markets.

Financial Size With annual revenue in the low tens of millions and a lean employee base, there is potential for scalable deployments, channel partnerships, and cost-effective collaborations with larger life sciences distributors or contract manufacturers seeking complementary immunology capabilities.